AzTrials
AzTrials

Cervical Spine DestabilizationCervistabNCT03712514

Behavior of the Upper Cervical Spine in Rugby Players

A study testing Destabilization of the upper cervical spine by Cervistab in people with Cervical Spine Destabilization, run by University Hospital, Montpellier at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Rugby players are often exposed to destabilisation of the upper cervical spine.This kind of trauma may lead to dramatic injuries, due to lesion of spinal cord. CerviStab© is a device which evaluate the bio-mechanical and neuromuscular behavior of the upper cervical spine in rugby situation. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Cervical Spine Destabilization
What is being tested?
Destabilization of the upper cervical spine by Cervistab
Could I receive a placebo?
No, everyone receives an active treatment
How many people
117 participants
Where
1 siteFrance
Study dates
23 Feb 2017to 23 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Rugby players at least since 5 years
  • Amateurs or professionals players
  • Able to play in rugby competition

Who cannot join

  • Medical history of cervical spine injury requiring surgical intervention
  • Active cervical symptomatology
  • Medical history of migraine or epilepsy

Trial locations and contacts

1 site in 1 country.

France1 site
  • Montpellier university Hospital

    Montpellier, 34090

Other trials in France

About this study

Official title: Dynamic Stabilization of the Upper Cervical Spine in a Cohort of Rugby's Players Via Ergometer (Cervistab©)

Rugby players are often exposed to destabilisation of the upper cervical spine.This kind of trauma may lead to dramatic injuries, due to lesion of spinal cord.

CerviStab© is a device which evaluate the bio-mechanical and neuromuscular behavior of the upper cervical spine in rugby situation.

The aim of this study, is to evaluate the dynamic stabilization of the upper cervical spine in reaction to unexpected impact.

Being tested
Destabilization of the upper cervical spine by Cervistab

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Destabilization of the upper cervical spine by CervistabOther

    Simulate a situation of destabilization of the cervical spine with Cervistab

Study groups in NCT03712514
Study groupRoleWhat they receive
Rugby playersOtherDestabilization of the upper cervical spine with Cervistab
Receives: Other: Destabilization of the upper cervical spine by Cervistab
Healthy non rugby playersOtherDestabilization of the upper cervical spine with Cervistab
Receives: Other: Destabilization of the upper cervical spine by Cervistab

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reproducibility of head movement amplitude measurements on healthy volunteers

    Measurement in millimetres by "Cervistab" ergometer

    Measured: Week 1

  2. Reproducibility of the measurement of mechanical resistance strength intensity produced by upper cervical spine muscles responding to destabilization on healthy volunteers

    Measurement in decanewtons by "Cervistab" ergometer

    Measured: Week 1

  3. Reproducibility of time until appearance of mechanical resistance strength produced by upper cervical spine muscles responding to destabilization on healthy volunteers

    Measurement in milliseconds by "Cervistab" ergometer

    Measured: Week 1

  4. Reproducibility of the time of response of upper cervical spine extensor muscles responding to destabilization on healthy volunteers

    Measurement in milliseconds by "Cervistab" ergometer

    Measured: Week 1

  5. Reproducibility of the amplitude of the response of upper cervical spine extensor muscles responding to destabilization on healthy volunteers

    Measurement in decanewtons by "Cervistab" ergometer

    Measured: Week 1

Secondary outcomes (6)
  1. Comparison of biomechanical behaviour of upper cervical spine dynamic stabilization capacities between healthy volunteers and rugby players

    Measurement by "Cervistab" ergometer

    Measured: Week 1

  2. Comparison of neuromuscular behaviour of upper cervical spine dynamic stabilization capacities between healthy volunteers and rugby players

    Measurement by "Cervistab" ergometer

    Measured: Week 1

  3. Comparison of biomechanical behaviour of upper cervical spine dynamic stabilization capacities between resting and acute fatigue situations in rugby players subjects

    Measurement by "Cervistab" ergometer

    Measured: Week 1

  4. Comparison of neuromuscular behaviour of upper cervical spine dynamic stabilization capacities between resting and acute fatigue situations in rugby players subjects

    Measurement by "Cervistab" ergometer

    Measured: Week 1

  5. Comparison of biomechanical behaviour of upper cervical spine dynamic stabilization capacities between male rugby players and female rugby players

    Measurement by "Cervistab" ergometer

    Measured: Week 1

  6. Comparison of neuromuscular behaviour of upper cervical spine dynamic stabilization capacities between male rugby players and female rugby players

    Measurement by "Cervistab" ergometer

    Measured: Week 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2018
  2. Study start23 Feb 2017
  3. Primary completion23 Sep 2021
  4. Study completion23 Sep 2021

Why it stopped: the inclusion period ended on 23/09/2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
117 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03712514
Sponsor's protocol ID
9536
Other IDs
2015-A00505-44
Acronym
Cervistab
Status last verified
Dec 2021
First submitted
27 Apr 2018
Last updated
30 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Destabilization of the upper cervical spine by Cervistab in people with Cervical Spine Destabilization, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 30 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: the inclusion period ended on 23/09/2021). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reproducibility of head movement amplitude measurements on healthy volunteers (time frame: Week 1). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in